{"podcast":{"title":"Metabolic Mind","slug":"metabolic-mind-6253550","podcast_index_feed_id":6253550,"rss_url":"https://feeds.captivate.fm/metabolic-mind/","website_url":"https://metabolicmind.org/","image_url":"https://artwork.captivate.fm/d5c870fb-4d35-464f-8bde-33ce9e2b58c4/MM-Podcast-cover-final.png","author":"Bret Scher","episode_count":224,"summary":"Metabolic Mind is working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. Metabolic interventions like ketogenic therapy are being used to treat serious mental illnesses like Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. We explore topics that can help you understand how Metabolic Psychiatry might help you or a loved one treat mental disorders Watch our videos at https://www.youtube.com/@metabolicmind Our channel is for information only. Consult your physician before changing your lifestyle or medications.","last_synced_at":"2026-07-24T00:18:08.497488+00:00","page_url":"https://stenobird.com/podcast/metabolic-mind-6253550"},"episode":{"title":"BITESIZE: New Study: Why Did This Drug Lower Cholesterol But Not Heart Plaque?","slug":"bitesize-new-study-why-did-this-drug-lower-cholesterol-but-not-heart-plaque","published_at":"2026-06-01T14:50:00+00:00","page_url":"https://stenobird.com/podcast/metabolic-mind-6253550/bitesize-new-study-why-did-this-drug-lower-cholesterol-but-not-heart-plaque","show_page_url":"https://stenobird.com/podcast/metabolic-mind-6253550","url":"https://metabolicmind.org/","audio_url":"https://episodes.captivate.fm/episode/1f537a41-d810-4d0a-901d-1892d5c72ed8.mp3","summary":"Lower triglycerides, lower remnant cholesterol, lower ApoB. Zero change in coronary artery plaque. A new clinical trial is forcing a bigger conversation about how we treat cardiovascular disease. The drug was Olezarsen, an APOC3 inhibitor. The blood work looked impressive. The heart scans did not. So why would lowering well-established cardiovascular risk factors fail to move the needle on plaque? Dr. Bret Scher argues there's a critical difference between what we want to fix and how we go about fixing it. Lowering a number with a drug is not the same as addressing the underlying metabolic dysfunction that caused that number to be high in the first place. In this video, you'll learn: What the Olezarsen trial actually showed and why the results matter Why elevated triglycerides often signal deeper metabolic dysfunction and insulin resistance How this same drug-first thinking plays out in type 2 diabetes, hypertension, and weight management Why narrowing our focus to \"fix the number\" can keep us from healing the whole system How metabolic medicine reframes the conversation around root causes This isn't an argument against medication. Responsible drug use has an important place in patient care. But the best outcomes come when we ask why a number is abnormal in the first place and what combination of lifestyle changes and targeted treatments will actually address it. 👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter/ 🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode. #MetabolicMind #KetogenicTherapy #CardiovascularDisease Expert Fea…","meta_description":"Lower triglycerides, lower remnant cholesterol, lower ApoB. Zero change in coronary artery plaque. A new clinical trial is forcing a bigger conversation a…","key_points":[],"chapters":[],"topics":[],"duration_seconds":213,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/metabolic-mind-6253550/episodes/bitesize-new-study-why-did-this-drug-lower-cholesterol-but-not-heart-plaque/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/metabolic-mind-6253550/bitesize-new-study-why-did-this-drug-lower-cholesterol-but-not-heart-plaque.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}